Feb 28 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX :
* H1 REVENUES FROM CONTINUING ACTIVITIES ROSE 3 PERCENT TO $7.2 MILLION
* H1 NET PROFIT FOR PERIOD ATTRIBUTED TO MEMBERS DOWN 44 PERCENT TO $1.4 MILLION
Feb 28 (Reuters) - Clinuvel Pharmaceuticals Ltd CUV.AX :
* H1 REVENUES FROM CONTINUING ACTIVITIES ROSE 3 PERCENT TO $7.2 MILLION
* H1 NET PROFIT FOR PERIOD ATTRIBUTED TO MEMBERS DOWN 44 PERCENT TO $1.4 MILLION